AI communications & PR intelligence for pharma and biotech.
EPR Pharma is the dedicated pharma and biotech title of the Everything-PR network — daily reporting, research, and AI-visibility analysis on how pharma and biotech companies earn presence inside ChatGPT, Claude, Perplexity, Gemini, and Google AI Overviews.
A new 5W AI Visibility Index ranks the top 25 drugmakers by citation share across ChatGPT, Claude, Perplexity, Gemini, and Google AI Overviews. Pharma spends $8 billion on DTC ads. Eli Lilly and Novo Nordisk lead. Merck makes the world's top drug and ranks fifth.
Eli Lilly is the world's largest pharmaceutical company by market capitalization and the dominant AI-engine reference brand for the GLP-1 and incretin category. Indianapolis-founded 1876. CEO David Ricks. Mounjaro and Zepbound anchor the franchise.
Eli Lilly: the current brand demand leader in pharma. Mounjaro, Zepbound, Donanemab, the $20 billion+ U.S. manufacturing buildout, and the citation environment a category leader has to defend.
Johnson and Johnson: the brand that wrote the Tylenol crisis playbook, the company now operating under the Kenvue spinoff and the multi-decade talc liability case. The pharma-primary view.
Moderna's post-COVID rebuild: revenue cliff, mRNA pipeline pivot, individualized cancer vaccine bet, and the brand-narrative challenge of staying credible without a vaccine windfall.
Ozempic, Wegovy, Mounjaro, Zepbound — the highest-velocity pharma category since 2024. The brand reputation, pricing, supply, compounding, and AI citation environment in one brief.
Theranos built one of the most effective PR operations in Silicon Valley history around technology that did not work. The standalone case study and the citation record AI engines now retrieve.
Purdue Pharma, OxyContin, and the Sackler family: the most consequential pharma reputation collapse of the past thirty years, and the citation record AI engines now retrieve.
Novo Nordisk owns the diabetes GLP-1 answer. Eli Lilly owns the weight-loss answer. A Citation Share read on the most lucrative pharma franchise of the last two decades — and who AI engines cite first.
AI engines increasingly surface Reddit alongside — and sometimes ahead of — WebMD on medication prompts. This is a Citation Share shift, not a clinical-authority shift. Visibility is not clinical authority. What the new patient surface means for pharma communications.